-
Mashup Score: 0
RiVive is the second nonprescription naloxone product approved by the FDA, signaling a proactive effort to increase accessibility and consumer availability of life-saving medication.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Health tech company ObservSMART partners with addiction-focused provider - 11 month(s) ago
Praesum Healthcare will use ObservSMART’s wearable and tablet technology to monitor patients in treatment facilities across five states.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Healthtech co @ObservS partners with #addiction-focused provider @praesumhealth which will use ObservSMART's #wearables and tablet technology to monitor patients in treatment facilities across five states. https://t.co/Tlg8cWdZwB
-
-
Mashup Score: 2Lead: Practice-Based Guidelines: Buprenorphine in the Age of Fentanyl - 12 month(s) ago
Lead Story The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission JCI Insight Evidence suggests that the glucagon-like-peptide-1 (GLP-1) system may be involved in the neurobiology of addiction. The authors studied the impact of semaglutide, a long acting GLP-1 analogue, on alcohol use in mice and rat models and found a…
Source: www.podbean.comCategories: Addiction Medicine, Latest HeadlinesTweet-
Check out the latest ASAM Weekly podcast, This Week in Addiction Medicine. Top story summaries and news from the field of addiction medicine. #podcast #TreatAddictionSaveLives #addiction #addictionmedicine https://t.co/d7PVDnjRoO on #Podbean
-
-
Mashup Score: 0Addiction recovery provider sees success with AI-enabled telehealth meds monitoring - 12 month(s) ago
In two years following 100 new-start opioid use disorder patients, Bill Farr says 94% remained in the medication-assisted treatment program – attrition rates had previously hovered around 54%.
Source: Healthcare IT NewsCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Addiction recovery provider sees success with #AI-enabled #telehealth meds monitoring - In 2 yrs following 100 #opioid use disorder patients, 94% remained in medication-assisted treatment program – attrition rates had previously hovered around 54% https://t.co/SJ1gQKLG98
-
-
Mashup Score: 6
This cross-sectional study assesses buprenorphine prescribing trends after the implementation of initiatives in New Jersey Medicaid designed to improve access.
Source: jamanetwork.comCategories: General Medicine News, Latest HeadlinesTweet-
NJ Medicaid reforms tied to increased use of opioid #addiction treatment @RutgersU @jamanetworkopen https://t.co/maiEDSfOJD https://t.co/E0Xkz8FxOX
-
-
Mashup Score: 1Congressional Briefing Emphasizes Actions Necessary to Address Substance Use Disorder Crisis - 1 year(s) ago
Smita Das, M.D., Ph.D., M.P.H. (pictured at left), chair of APA’s Council on Addiction Psychiatry, was among a panel of experts who spoke t…
Source: alert.psychnews.orgCategories: Latest Headlines, PsychiatryTweet-
A panel of experts spoke to members of Congress and their staff on Wednesday about the #addiction crisis in this country and what actions Congress can take to address it. https://t.co/Hgo9IOIQ8s #PsychTwitter #MedTwitter #MentalHealth
-
-
Mashup Score: 0FDA approves over-the-counter Narcan. Here's what it means - 1 year(s) ago
The U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter.
Source: WDIVCategories: General Medicine News, Latest HeadlinesTweet-
The FDA recently approved the leading version of naloxone, an overdose-reversing drug, to be sold over the counter without a prescription. Watch our director of #addiction medicine Dr. Elizabeth Bulat discuss with @clickondetroit: https://t.co/0fRTZ9Z611
-
-
Mashup Score: 0African Psychedelic Plant Inspires Design of Antidepressant and Anti-Addiction Candidates - 1 year(s) ago
Computational docking strategy identifies selective SERT inhibitors that were 200 times more potent than the antidepressant fluoxetine, blunting symptoms in mice.
Categories: Future of Medicine, Latest HeadlinesTweet-
The pharmacology of a traditional African psychedelic plant medicine called ibogaine has led to the development of two new drug candidates for potentially treating #addiction and #depression. Learn more:https://t.co/OvAGZiq8vG https://t.co/EL2CnF8qJ4
-
-
Mashup Score: 10African Psychedelic Plant Inspires Design of Antidepressant and Anti-Addiction Candidates - 1 year(s) ago
Computational docking strategy identifies selective SERT inhibitors that were 200 times more potent than the antidepressant fluoxetine, blunting symptoms in mice.
Categories: Future of Medicine, Latest HeadlinesTweet-
The pharmacology of a traditional African psychedelic plant medicine called ibogaine has led to the development of two new drug candidates for potentially treating #addiction and #depression. Learn more:https://t.co/OvAGZiq8vG https://t.co/PmN4O1Ix50
-
-
Mashup Score: 75 action steps for quitting an addiction - Harvard Health - 1 year(s) ago
Because change is so difficult, it’s useful to have a guide when attempting to kick an addiction to drugs, alcohol or behavior. Research shows that the following steps can help you move toward your…
Source: Harvard HealthCategories: General Medicine News, Latest HeadlinesTweet-
It's useful to have a guide when attempting to kick an #addiction to drugs, alcohol or behavior. Research shows that these 5 steps can help you move toward your recovery goals. #HarvardHealth https://t.co/YNloGkj54K
-
The data demonstrated that RiVive nasal spray achieved similar levels of effectiveness as an FDA-approved prescription naloxone product. https://t.co/lYTscSLhfU @US_FDA #addiction #FDA